NN2211-4077 Retrospective collection of effectiveness and safety data from patients treated with liraglutide or DPP-4 inhibitor in primary care in Europe

First published 27/02/2015

Last updated 02/04/2024

EU PAS number:

EUPAS8135

Study

Finalised

Documents

Study protocol

Initial protocol

4077-protocol-version-2-7-nw-redacted

English (392.69 KB - PDF)View document

Study results

4077-ctr-redacted

English (869.72 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs